Announcements Trials
Browse Landscape

Phase

Phase 2 1Phase 1/2 1

Status

Unknown 1Completed 1

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Interventional 2

Sponsor

Cancer Type

CNS 2

Conditions

Glioblastoma 10Glioma 8Brain Neoplasms 4Seizures 2Spinal Cord Neoplasms 1Osteoarthritis, Spine 1Oligodendroglioma 1Neoplasms 1Neoplasm Metastasis 1Medulloblastoma 1Hemostasis 1Hemianopsia 1Diffuse Intrinsic Pontine Glioma 1Central Nervous System Neoplasms 1Bone Diseases 1Astrocytoma 1

Interventions

Levetiracetam 6perampanel 2Tranexamic Acid 2Standard of Care 2ziprasidone 1Zolpidem 1Warfarin 1Vecuronium Bromide 1Vancomycin 1Tobramycin 1Temozolomide 1Spironolactone 1Sodium Chloride 1Sevelamer 1Saline Solution 1Rocuronium 1Pregabalin 1Piperacillin, Tazobactam Drug Combination 1Pentobarbital 1Oxycodone 1Nifedipine 1Nafcillin 1Molindone 1Methylprednisolone 1Mental Status and Dementia Tests 1Magnetic Resonance Spectroscopy 1Magnesium Sulfate 1Lurasidone Hydrochloride 1Labetalol 1Haloperidol 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Seizures × Standard of Care × CNS × Clear all
NCT04497142 2024-08-05

Effect of Perampanel on Peritumoral Hyperexcitability in HGG

Dana-Farber Cancer Institute

Phase 1/2 Completed
12 enrolled 8 charts
CNS

Glioma, Seizures

NCT04450160 2020-06-29

AEO

MetVital, Inc.

Phase 2 Unknown
80 enrolled
CNS

Glioblastoma, Seizures

Data powered by HemOnc (CC BY 4.0) Colophon âš¡